Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Clin Infect Dis. 2012 Dec;55 Suppl 4(Suppl 4):S225-31. doi: 10.1093/cid/cis787.
The overall aim of the Global Enteric Multicenter Study-1 (GEMS-1) is to identify the etiologic agents associated with moderate-to-severe diarrhea (MSD) among children <5 years of age, and thereby the attributable pathogen-specific population-based incidence of MSD, to guide investments in research and public health interventions against diarrheal disease. To accomplish this, 9 core assumptions were vetted through widespread consultation: (1) a limited number of etiologic agents may be responsible for most MSD; (2) a definition of MSD can be crafted that encompasses cases that might otherwise be fatal in the community without treatment; (3) MSD seen at sentinel centers is a proxy for fatal diarrheal disease in the community; (4) matched case/control is the appropriate epidemiologic design; (5) methods across the sites can be standardized and rigorous quality control maintained; (6) a single 60-day postenrollment visit to case and control households creates mini-cohorts, allowing comparisons; (7) broad support for GEMS-1 messages can be achieved by incorporating advice from public health spokespersons; (8) results will facilitate the setting of investment and intervention priorities; and (9) wide acceptance and dissemination of the GEMS-1 results can be achieved.
全球肠道疾病多中心研究 1 期(GEMS-1)的总体目标是确定与 5 岁以下儿童中度至重度腹泻(MSD)相关的病原体,从而明确导致 MSD 的病原体在特定人群中的发病率,为腹泻病的研究和公共卫生干预措施提供指导。为了实现这一目标,经过广泛协商,对 9 项核心假设进行了审查:(1)可能只有少数病原体是导致大多数 MSD 的原因;(2)可以制定一个 MSD 的定义,涵盖在没有治疗的情况下可能在社区中致命的病例;(3)哨点中心看到的 MSD 是社区中致命腹泻病的代表;(4)匹配的病例对照是适当的流行病学设计;(5)各站点的方法可以标准化,并保持严格的质量控制;(6)对病例和对照家庭进行单次 60 天的随访访问可创建小型队列,从而进行比较;(7)通过纳入公共卫生发言人的建议,可以获得对 GEMS-1 信息的广泛支持;(8)研究结果将有助于确定投资和干预措施的优先顺序;(9)广泛接受和传播 GEMS-1 的结果。